What's new? Log in Free sign up

Filing search / VBI Vaccines Inc / "Oversight"

Search information

VBI Vaccines Inc

Companies

"Oversight"

Keywords

SEC filings

Source

Export list of results

Export a CSV file of filings or unique companies (up to first 5,000 results).

Download list of filings Download list of companies

59 results

Newest first Best match first

VBIVQ VBI Vaccines Inc

VBI Vaccines Initiates Restructuring Proceedings Under CCAA to Implement a Review of its Strategic Alternatives

for the sale process under the supervision of the CCAA Court and the general oversight of the Monitor. VBI intends to fund the CCAA process from cash on hand

VBIVQ VBI Vaccines Inc

Definitive proxy

of the Board of Directors and Executive Officers – page 14 Code of Business Conduct and Ethics – page 14 Risk Oversight – page 15 Board Leadership … with EisnerAmper LLP the matters required to be discussed by the applicable requirements of the Public Company Accounting Oversight Board and the SEC

29 Apr 24

4:05pm

VBIVQ VBI Vaccines Inc

control or oversight as one would have at its own facility. Furthermore, following the completion of the sale of the Rehovot facility, if the sale … of such prohibitions, individual imprisonment, additional reporting obligations, and oversight (if we become subject to a corporate integrity agreement

16 Apr 24

8:01am

VBIVQ VBI Vaccines Inc

Quarterly report

) provide advice and oversight for Manufacturing during the development and commercialization of Products; (c) discuss the Commercial Manufacturing

14 Nov 23

4:06pm

VBIVQ VBI Vaccines Inc

VBI Vaccines Announces Proposed Concurrent Public Offering and Registered Direct Offering of Common Shares and Warrants

and the Public Company Accounting Oversight Board (United States) and applicable Canadian securities laws and Rule 204 of the Canadian Chartered Professional

Definitive proxy

1 May 23

4:05pm

w3phvs421kjapny63bj

Quarterly report

10 Nov 22

8:00am

Shelf registration

26 Aug 22

4:55pm

VBI Vaccines Announces Appointment of John Dillman as Chief Commercial Officer

Definitive proxy

29 Apr 22

4:51pm

Preliminary proxy

18 Apr 22

4:45pm

vnk3a ejhpl1kmsfr3bg

7 Mar 22

8:01am

7 Mar 22

8:01am

Entry into a Material Definitive Agreement

Quarterly report

10 May 21

8:00am

Definitive proxy

26 Apr 21

9:00am

2 Mar 21

8:00am

2 Mar 21

8:00am

VBI Vaccines Selects Syneos Health as Commercialization Partner for Prophylactic 3-Antigen Hepatitis B Vaccine

zqf458mz qnbmaxed10

Automatic shelf registration

Prev
1
2
3
Next

We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.